Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

http://www.wikidata.org/entity/Q36105529

about

PLK1, A Potential Target for Cancer Therapy PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.Volasertib suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation.PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.Polo-like-kinase 1: A key cellular target for anti-HBV therapy?Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.Performance of Pyridylthiourea-Polyethylenimine Polyplex for siRNA-Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models

P2860

Q28078772-4335EE96-F002-4A4B-A3FA-47E62E2552B4 Q35951377-BF07E487-574B-4500-ACF7-A564AC7EE8E5 Q36962637-40F4657C-602C-4552-A7DD-6BC2D4F38F40 Q37447866-B92D3AFD-59C3-480E-A718-53F4FF8F5A47 Q39146648-985D8548-E60E-4507-A5EB-EE25596436D0 Q39200418-C0679F33-D673-444C-8913-B0888A4250B9 Q42060938-0666819E-42D8-41C4-A539-1D65E711A174 Q45068538-DB4BDAF5-09FA-43B3-86BF-2089B781E959 Q46606052-0D084D77-8DE7-4A60-99E4-4B3CCAED9FB3 Q47691844-AA1EDECE-EC25-47C2-99A5-7D83B57DC534 Q49402953-294FDA41-C49C-445B-A9B9-B20AD4233172 Q58002758-9D3696E0-2FA3-4166-B117-35D524091EF8

P2860

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

http://www.wikidata.org/entity/Q36105529

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@ast

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@en

type

label

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@ast

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@en

prefLabel

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@ast

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@en

P1433

Q36105529-807AC378-0E31-4811-8C6C-E6BCD8BC27F0

P1476

Q36105529-6CAEDB2B-965F-4DDC-BE84-264282057CE5

P2093

Q36105529-2E3477E5-2D1C-4FD0-A6A5-278F3631DDB0

Q36105529-9BF51EDA-4966-4875-A928-71719E845909

Q36105529-E10BBA78-0960-40D7-93B2-339F3C33A403

P2860

Q36105529-03443115-0CDD-4ABA-8991-1584B968ECFD

Q36105529-0D90218B-978D-484B-8931-563E441BA9F8

Q36105529-111DC2FB-6F6E-4D68-9EDC-72266686D60C

Q36105529-12239145-F33A-43BF-B6A7-01D7C8ABF159

Q36105529-2E2E4357-24F0-4D3F-85B7-E37B8A4FE980

Q36105529-41D5A54E-A66A-4C14-B051-68A8EEA747B4

Q36105529-48BA3D2C-7803-4FB7-BA6A-7A7D06B38683

Q36105529-5218D57B-7C64-4FC9-B486-527F2104B32A

Q36105529-647671E2-ED9C-417A-9E42-CEF3907D3EAD

Q36105529-6F30C22A-2C8F-4870-8E86-8351F33B4314

P304

Q36105529-08BDC1A7-05D6-469D-9FB5-B682185059DB

P31

Q36105529-8B3A75DD-0E3E-4E41-9DAD-5703768F228E

P356

Q36105529-A3320C2D-DA15-4435-AD49-9832E979C643

P407

Q36105529-42BBCF58-B264-46CC-ABB8-E710C5062B9B

P433

Q36105529-5FE9F837-0BCB-4B13-B997-DBE5724BAEF6

P478

Q36105529-23E8EB8A-B485-438C-A295-904475B26DBC

P50

Q36105529-4FB67A26-32A4-4204-ABEE-4C13CE23FCC8

P577

Q36105529-1598330C-500C-4B5D-9E74-44B44DB313F6

P5875

Q36105529-0CABB44F-13EC-4ADD-B6DD-B87296023105

P698

Q36105529-DD6785AB-64C4-40C9-941F-F220ED75C14A

P932

Q36105529-79034244-8400-4F64-8947-2E215EAFE7AC

P356

WJG.V18.I27.3527

P1433

World Journal of Gastroenterology

P1476

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma

@en

P2093

Seng Gee Lim

http://www.w3.org/2001/XMLSchema#string

Shanthi Wasser

http://www.w3.org/2001/XMLSchema#string

Wei Chuen Mok

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome

Sorafenib in advanced hepatocellular carcinoma

Endonuclease G is an apoptotic DNase when released from mitochondria

Polo-like kinases and the orchestration of cell division

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Role of AIF in caspase-dependent and caspase-independent cell death.

Polo-like kinases and oncogenesis.

Normal cells, but not cancer cells, survive severe Plk1 depletion.

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.

P304

3527-3536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I27.3527

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229554675

http://www.w3.org/2001/XMLSchema#string

P698

22826617

http://www.w3.org/2001/XMLSchema#string

P932

3400854

http://www.w3.org/2001/XMLSchema#string